Literature DB >> 15809306

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha.

Kathleen Aertgeerts1, Irena Levin, Lihong Shi, Gyorgy P Snell, Andy Jennings, G Sridhar Prasad, Yanming Zhang, Michelle L Kraus, Shant Salakian, Vandana Sridhar, Robert Wijnands, Mike G Tennant.   

Abstract

Fibroblast activation protein alpha (FAPalpha) is highly expressed in epithelial cancers and has been implicated in extracellular matrix remodeling, tumor growth, and metastasis. We present the first high resolution structure for the apoenzyme as well as kinetic data toward small dipeptide substrates. FAPalpha exhibits a dipeptidyl peptidase IV (DPPIV)-like fold, featuring an alpha/beta-hydrolase domain and an eight-bladed beta-propeller domain. Known DPPIV dipeptides are cleaved by FAPalpha with an approximately 100-fold decrease in catalytic efficiency compared with DPPIV. Moreover, FAPalpha, but not DPPIV, possesses endopeptidase activity toward N-terminal benzyloxycarbonyl (Z)-blocked peptides. Comparison of the crystal structures of FAPalpha and DPPIV revealed one major difference in the vicinity of the Glu motif (Glu(203)-Glu(204) for FAPalpha; Glu(205)-Glu(206) for DPPIV) within the active site of the enzyme. Ala(657) in FAPalpha, instead of Asp(663) as in DP-PIV, reduces the acidity in this pocket, and this change could explain the lower affinity for N-terminal amines by FAPalpha. This hypothesis was tested by kinetic analysis of the mutant FAPalpha/A657D, which shows on average an approximately 60-fold increase in the catalytic efficiency, as measured by k(cat)/K(m), for the cleavage of dipeptide substrates. Furthermore, the catalytic efficiency of the mutant is reduced by approximately 350-fold for cleavage of Z-Gly-Pro-7-amino-4-methylcoumarin. Our data provide a clear understanding of the molecular determinants responsible for the substrate specificity and endopeptidase activity of FAPalpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809306     DOI: 10.1074/jbc.C500092200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets.

Authors:  Petr Busek; Petr Hrabal; Premysl Fric; Aleksi Sedo
Journal:  Histochem Cell Biol       Date:  2014-11-02       Impact factor: 4.304

Review 2.  The expanding diversity of serine hydrolases.

Authors:  Istvan Botos; Alexander Wlodawer
Journal:  Curr Opin Struct Biol       Date:  2007-09-24       Impact factor: 6.809

3.  Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.

Authors:  Aaron M LeBeau; W Nathaniel Brennen; Saurabh Aggarwal; Samuel R Denmeade
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

4.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

Review 5.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

6.  The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus.

Authors:  Daniela Justa-Schuch; Ulrike Möller; Ruth Geiss-Friedlander
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

7.  Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.

Authors:  Xiuying Li; Yongsheng Wang; Yuwei Zhao; Hengxiu Yang; Aiping Tong; Chengjian Zhao; Huashan Shi; Yang Li; Zhenlin Wang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

8.  Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.

Authors:  Liang-Chuan S Wang; Albert Lo; John Scholler; Jing Sun; Rajrupa S Majumdar; Veena Kapoor; Michael Antzis; Cody E Cotner; Laura A Johnson; Amy C Durham; Charalambos C Solomides; Carl H June; Ellen Puré; Steven M Albelda
Journal:  Cancer Immunol Res       Date:  2013-11-12       Impact factor: 11.151

9.  Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.

Authors:  Alanna Kennedy; Huan Dong; Donghai Chen; Wen-Tien Chen
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

10.  Induced-fit mechanism for prolyl endopeptidase.

Authors:  Min Li; Changqing Chen; David R Davies; Thang K Chiu
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.